February 8, 2024 Indrani FranchiniAlnylam Pharmaceuticals, Inc. • March 4th, 2024 • Pharmaceutical preparations
Company FiledMarch 4th, 2024 IndustryThis letter agreement is to summarize the terms of the separation package to which you and Alnylam Pharmaceuticals, Inc. (the “Company”) have agreed. Please read this letter agreement, which includes a general release (this “Letter Agreement”), carefully. If you are willing to agree to its terms, please sign in the space provided below and return it to me so that your separation benefits can begin. Please note that, in order to be effective, you cannot sign this Letter Agreement until after the Separation Date (as defined below), and must do so no later than March 5, 2024 if you want to accept its terms.